US 8729053
Nuclear factor kappa B pathway inhibitor composition and use of same
granted A61KA61K31/10A61K31/635
Quick answer
US patent 8729053 (Nuclear factor kappa B pathway inhibitor composition and use of same) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/10, A61K31/635, A61K31/655, A61P